Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000135

Chairperson & CEO sold 9,500 shares at an average $487.54 ($4,631,619)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

14 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-03 Exercise or conversion : show line 1 in the form 10b5-1 +8,910 $135.42 $1,206,592 333,353 I
2026-09-03 Exercise or conversion : show line 2 in the form 10b5-1 +590 $117.76 $69,478 333,943 I
2026-09-03 Sale : show line 3 in the form 10b5-1 −200 $479.07 $95,813 333,743 I
2026-09-03 Sale : show line 4 in the form 10b5-1 −440 $480.53 $211,431 333,303 I
2026-09-03 Sale : show line 5 in the form 10b5-1 −600 $481.47 $288,884 332,703 I
2026-09-03 Sale : show line 6 in the form 10b5-1 −400 $482.35 $192,938 332,303 I
2026-09-03 Sale : show line 7 in the form 10b5-1 −80 $483.69 $38,695 332,223 I
2026-09-03 Sale : show line 8 in the form 10b5-1 −240 $485.16 $116,438 331,983 I
Open-market sales · 9,500 sh · avg $487.54 · $4,631,619

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-09-03 Exercise or conversion : show line 15 in the form 10b5-1 Stock Option −8,910 0 I
2026-09-03 Exercise or conversion : show line 16 in the form 10b5-1 Stock Option −590 499,410 I
Loading xslF345X06/primarydocument.xml…